PRESS RELEASE published on 06/26/2024 at 23:30, 1 year 10 months ago Communiqué de presse : Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans Publication dans le NEJM des données positives de phase III du Dupixent dans le traitement de l’œsophagite à éosinophiles de l’enfant âgé de 12 mois à 11 ans. Résultats encourageants pour les jeunes patients Dupixent Phase III Œsophagite À Éosinophiles NEJM Enfant
PRESS RELEASE published on 06/26/2024 at 23:30, 1 year 10 months ago Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Positive phase 3 data of Dupixent in children aged 1-11 with eosinophilic esophagitis published in NEJM highlights significant histologic remission achieved and sustained improvements, potentially changing standard of care Children Phase 3 Study Dupixent Eosinophilic Esophagitis NEJM Publication
BRIEF published on 06/25/2024 at 19:37, 1 year 10 months ago Sanofi Releases Q2 2024 Aide-Mémoire to Assist Financial Modelling Financial Results Investors Q2 2024 Sanofi Aide-mémoire
BRIEF published on 06/25/2024 at 19:37, 1 year 10 months ago Sanofi publie un aide-mémoire du deuxième trimestre 2024 pour faciliter la modélisation financière Résultats Financiers Investisseurs Sanofi T2 2024 Aide Mémoire
PRESS RELEASE published on 06/25/2024 at 19:32, 1 year 10 months ago Press Release: Availability of the Q2 2024 Aide-mémoire Sanofi announces availability of Q2 2024 Aide-mémoire, assisting in financial modeling of quarterly results. Document includes non-comparable items, exclusivity losses, and more Q2 2024 Quarterly Results Sanofi Financial Modeling Aide-mémoire
PRESS RELEASE published on 06/25/2024 at 19:32, 1 year 10 months ago Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 » Sanofi annonce la mise en ligne du document "Aide-mémoire Q2 2024" sur son site internet. Ce document fournit des informations clés pour la modélisation des résultats trimestriels et sera suivi de l'annonce des résultats du 2e trimestre 2024 le 25 juillet Investisseurs Résultats Trimestriels Sanofi Aide-mémoire Document
BRIEF published on 06/21/2024 at 09:35, 1 year 10 months ago Sanofi nomme Audrey Duval Derveloy Directrice Affaires Corporate Groupe Comité Exécutif Nomination Responsabilité Sociale Sanofi Audrey Duval Derveloy
BRIEF published on 06/21/2024 at 09:35, 1 year 10 months ago Sanofi appoints Audrey Duval Derveloy Group Corporate Affairs Director Executive Committee Social Responsibility Nomination Sanofi Audrey Duval Derveloy
PRESS RELEASE published on 06/21/2024 at 09:30, 1 year 10 months ago Communiqué de presse : Audrey Duval Derveloy nommée Directrice Affaires Corporate Groupe, membre du Comité exécutif de Sanofi Audrey Duval Derveloy devient Vice-Présidente Exécutive, Directrice Affaires Corporate Groupe de Sanofi. Membre du Comité exécutif, elle supervisera l'engagement des parties prenantes à l'échelle mondiale Comité Exécutif Nomination Sanofi Audrey Duval Derveloy Directrice Affaires
PRESS RELEASE published on 06/21/2024 at 09:30, 1 year 10 months ago Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
Published on 05/07/2026 at 05:40, 3 hours 23 minutes ago New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 7 hours 3 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 9 hours 33 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 9 hours 58 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 10 hours 3 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/07/2026 at 08:48, 15 minutes ago Finnvera’s Annual General Meeting: New members to Finnvera’s Board of Directors and Supervisory Board
Published on 05/07/2026 at 08:36, 27 minutes ago Cherry SE publishes results for the first quarter of 2026 – Operating profitability significantly improved
Published on 05/07/2026 at 08:30, 32 minutes ago L'UE mise sur une politique climatique axée sur le marché: allègement des péages et des normes CO₂ pour les poids lourds
Published on 05/07/2026 at 07:43, 1 hour 19 minutes ago ENGIE - Information Financière 1er trimestre 2026
Published on 05/06/2026 at 18:00, 15 hours 3 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 15 hours 3 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 15 hours 3 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026